SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-046871
Filing Date
2020-08-14
Accepted
2020-08-14 21:00:09
Documents
2
Period of Report
2020-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6415
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4604
  Complete submission text file 0001209191-20-046871.txt   12529
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102
Business Address
BOBULSKY SUSAN (Reporting) CIK: 0001820885 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38957 | Film No.: 201107772